Predictors of the efficacy of non-drug treatments for non-dementia vascular cognitive impairment

Close metadata

OBJECTIVE

To study the predictors of the efficacy of non-drug multimodal therapy in the treatment of mild vascular cognitive impairment.

MATERIAL AND METHODS

Thirty patients with mild vascular cognitive impairment, under the supervision of their physician, received a 1-month non-drug treatment program including cognitive training, detailed recommendations for physical activity, and dietary planning.

RESULTS

After the end of the course of treatment, improvements in the MoCa test were achieved by 22 patients (73%), which made up Group 1. In the remaining 8 patients, the treatment had no effect (Group 2). In Group 1, the dynamics of the MoCa test averaged 1.7±0.9, in the Group 2 it was (–0.4)±0.5. Patients of Group 1 had a significantly lower level of education (10.9±2.3) compared with Group 2 (14.9±2.0), a higher initial MoCa score, and a less pronounced white matter lesion on the Fazekas scale. After the regression analysis, the level of education (B –0.999, p<0.05) and white matter damage (B –2.761, p<0.01) were significant predictors.

CONCLUSION

When using non-drug multimodal therapy in the treatment of mild vascular cognitive impairment, lower levels of education and a lower degree of white matter vascular damage are reliable predictors of treatment efficacy.

Keywords:

moderate vascular cognitive impairment

cognitive training

non-drug therapies

treatment predictors

Authors:

Novikova M.S.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-8382-6366

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0002-8447-3264

Received:

09.11.2022

Accepted:

18.01.2023

List of references:

Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimers Dis Other Demen. 2018;33(8):500-507. https://doi.org/10.1177/1533317518791401
Starchina YuA. Non-dementia cognitive impairment: a modern view of the problem. Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):71-76. (In Russ.). https://doi.org/10.14412/2074-2711-2017-2-71-76
Yakhno NN, Lokshina AB, Zakharov VV, et al. Syndrome of moderate cognitive impairment in the Russian population. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2019;119(5):179. (In Russ.). https://doi.org/10.17116/jnevro201911905S
Amieva H, Robert PH, Grandoulier AS, et al. Group and individual cognitive therapies in Alzheimer’s disease: the ETNA3 randomized trial. Int Psychogeriatr. 2016;28(5):707-717. https://doi.org/10.1017/S1041610215001830
Singh B, Parsaik AK, Mielke MM, et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;39(2):271-282. https://doi.org/10.3233/JAD-130830
Solfrizzi V, Custodero C, Lozupone M, et al. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review. J Alzheimers Dis. 2017;59(3):815-849. https://doi.org/10.3233/JAD-170248
Kessels RP, Eikelboom WS, Schaapsmeerders P, et al. Effect of Formal Education on Vascular Cognitive Impairment after Stroke: A Meta-analysis and Study in Young-Stroke Patients. J Int Neuropsychol Soc. 2017;23(3):223-238. https://doi.org/10.1017/S1355617716001016
Shimada H, Doi T, Lee S, Makizako H. Reversible predictors of reversion from mild cognitive impairment to normal cognition: a 4-year longitudinal study. Alzheimers Res Ther. 2019;11(1):24. https://doi.org/10.1186/s13195-019-0480-5
Pandya SY, Lacritz LH, Weiner MF, et al. Predictors of reversion from mild cognitive impairment to normal cognition. Dement Geriatr Cogn Disord. 2017;43(3-4):204-214. https://doi.org/10.1159/000456070
Osone A, Arai R, Hakamada R, Shimoda K. Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment: after 12 months of follow-up. Int J Geriatr Psychiatry. 2016;31(7):740-748. https://doi.org/10.1002/gps.4386
Osone A, Arai R, Hakamada R, Shimoda K. Cognitive and brain reserve in conversion and reversion in patients with mild cognitive impairment over 12 months of follow-up. J Clin Exp Neuropsychol. 2016;38(10):1084-1093. https://doi.org/10.1080/13803395.2016.1191620
Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255-2263. https://doi.org/10.1016/S0140-6736(15)60461-5
Roheger M, Kalbe E, Corbett A, et al. Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training? Brain Behav. 2021;11(11):e2388. https://doi.org/10.1002/brb3.2388
Shigihara Y, Hoshi H, Poza J, et al. Predicting the outcome of non-pharmacological treatment for patients with dementia-related mild cognitive impairment. Aging (Albany NY). 2020;12(23):24101-24116. https://doi.org/10.18632/aging.202270
Hsu TJ, Tsai HT, Hwang AC, et al. Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia. Geriatr Gerontol Int. 2017;(17 suppl 1):28-35. https://doi.org/10.1111/ggi.13037
Roheger M, Kalbe E, Corbett A, et al. Predictors of changes after reasoning training in healthy adults. Brain Behav. 2020;10(12):e01861. https://doi.org/10.1002/brb3.1861
Roheger M, Kalbe E, Corbett A, et al. Lower cognitive baseline scores predict cognitive training success after 6 months in healthy older adults: Results of an online RCT. Int J Geriatr Psychiatry. 2020;35(9):1000-1008. https://doi.org/10.1002/gps.5322
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015-1022. https://doi.org/10.1016/j.jalz.2015.04.011
Ciesielska N, Sokołowski R, Mazur E, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50(5):1039-1052. https://doi.org/10.12740/PP/45368
Meng X, D’Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One. 2012;7(6):e38268. https://doi.org/10.1371/journal.pone.0038268
Xu W, Tan L, Wang HF, et al. Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies. Mol Neurobiol. 2016;53(5):3113-3123. https://doi.org/10.1007/s12035-015-9211-5
Park S, Ryu SH, Yoo Y, et al. Neural predictors of cognitive improvement by multi-strategic memory training based on metamemory in older adults with subjective memory complaints. Sci Rep. 2018;8(1):1095. https://doi.org/10.1038/s41598-018-19390-2
Clark DO, Xu H, Unverzagt FW, Hendrie H. Does targeted cognitive training reduce educational disparities in cognitive function among cognitively normal older adults? Int J Geriatr Psychiatry. 2016;31(7):809-817. https://doi.org/10.1002/gps.4395
Middelstädt J, Folkerts AK, Blawath S, Kalbe E. Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression. J Alzheimers Dis. 2016;54(1):253-268. https://doi.org/10.3233/JAD-160181
DeTore NR, Mueser KT, Byrd JA, McGurk SR. Cognitive functioning as a predictor of response to comprehensive cognitive remediation. J Psychiatr Res. 2019;113:117-124. https://doi.org/10.1016/j.jpsychires.2019.03.012
Moscoso D, Martín F. Vocabulary, Grammar, Sex, and Aging. Cognitive Science. 2017;41(4):950-975. https://doi.org/10.1111/cogs.12367
Chen X, Duan L, Han Y, et al. Predictors for vascular cognitive impairment in stroke patients. BMC Neurol. 2016;16:115. https://doi.org/10.1186/s12883-016-0638-8
Baker LD, Frank LL, Foster-Schubert K, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71-79. https://doi.org/10.1001/archneurol.2009.307
Wang Y, Yang Y, Wang T, et al. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease. J Stroke Cerebrovasc Dis. 2020;29(12):105275. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105275
Boutzoukas EM, O’Shea A, Kraft JN, et al. Higher white matter hyperintensity load adversely affects pre-post proximal cognitive training performance in healthy older adults. Geroscience. 2022;44(3):1441-1455. https://doi.org/10.1007/s11357-022-00538-y
Innes KE, Selfe TK, Khalsa DS, Kandati S. Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial. J Alzheimers Dis. 2017;56(3):899-916. https://doi.org/10.3233/JAD-160867

Falls in elderly and senile patients. Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1030

Chronic pain in elderly and senile patients. Russian Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1033

Clinical recommendations of the Ministry of Health of Russia «Gonarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/667_1

Clinical recommendations of the Ministry of Health of Russia «Coxarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/666_1

Iovu M, Dumais G, du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoart Cart. 2008;16 Suppl 3:S14-18. https://doi.org/10.1016/j.joca.2008.06.008

Du Souich P, Garcia A,Verges J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;3(8A):1451-1463. https://doi.org/10.1111/j.1582-4934.2009.00826.x

de Abajo F, Gil M, Garcia Poza P, et al. Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol Drug Saf. 2014;23:1128-1138. https://doi.org/10.1002/pds.3617

King D, Xiang J. Glucosamine/Chondroitin and Mortality in a US NHANES Cohort. J Am Board Fam Med. 2020;33(6):842-847. https://doi.org/10.3122/jabfm.2020.06.200110

Bell G, Kantor E, Lampe J, et al. Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012;27(8):593-603. https://doi.org/10.1007/s10654-012-9714-6

Morrison L. Reduction of ischemic coronary heart disease by chondroitin sulfate. Angiology. 1971;22(3):165-174. https://doi.org/10.1177/000331977102200308

Morrison L, Enrick N. Coronary Heart Disease: Reduction of Death Rate By Chondroitin Sulfate. Angiology. 1973;24(5):269-287. https://doi.org/10.1177/000331977302400503

Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects. Clinical Trial. Z Alternsforsch. 1979;34(2):153-159.

Mazzucchelli R, Rodrı´guez-Martı´n S, Garcı´a-Vadillo A, et al. Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study. PLoS ONE. 2021;16(7):e0253932. https://doi.org/10.1371/journal.pone.0253932

Melgar-Lesmes P, Sánchez-Herrero A, Lozano-Juan F, et al. Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response. Thromb. Haemost. 2018;118(7):1329-1339. https://doi.org/10.1055/s-0038-1657753

Williams K, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15(5):551-561. https://doi.org/10.1161/01.atv.15.5.551

Adhikara I, Yagi K, Mayasari D, et al. Chondroitin Sulfate Nacetylgalactosaminyltransferase-2 Impacts Foam Cell Formation and Atherosclerosis by Altering Macrophage Glycosaminoglycan Chain. Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1076-1091. https://doi.org/10.1161/ATVBAHA.120.315789

Bell J, Rhind S, Di Battista A, et al. Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. Neurocrit Care. 2016;26(3):339-347. https://doi.org/10.1007/s12028-016-0357-4

Nuytemansa K, Ortelb T, Gomeza L, et al. Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thromb Res. 2018;161:43-51. https://doi.org/10.1016/j.thromres.2017.11.016

Ye J, Esmon C, Johnson A. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem. 1993;268(4):2373-2379.

McGee M, Wagner W. Chondroitin Sulfate Anticoagulant Activity Is Linked to Water Transfer Relevance to Proteoglycan Structure in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(10):1921-1927. https://doi.org/10.1161/01.ATV.0000090673.96120.67

Moroudas A, Weinberg P, Parker K, Winlove C. The distribution and diffusion of small ions in chondroitin sulfate, hyaluronate and some proteoglycans solutions. Biophys Chem. 1988;32(2-3):257-270. https://doi.org/10.1016/0301-4622(88)87012-1

Close metadata